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Alternate access modelProkaryotic solute binding protein-dependent ATP-binding cassette import systems are divided into type I and
type II and mechanistic differences in the transport process going along with this classiﬁcation are under inten-
sive investigation. Little is known about the conformational dynamics during the catalytic cycle especially
concerning the transmembrane domains. The type I transporter for positively charged amino acids from
Salmonella enterica serovar Typhimurium (LAO-HisQMP2) was studied by limited proteolysis in detergent solu-
tion in the absence and presence of co-factors including ATP, ADP, LAO/arginine, and Mg2+ ions. Stable peptide
fragments could be obtained and differentially susceptible cleavage siteswere determined bymass spectrometry
as Lys-258 in the nucleotide-binding subunit, HisP, and Arg-217/Arg-218 in the transmembrane subunit, HisQ. In
contrast, transmembrane subunit HisM was gradually degraded but no stable fragment could be detected. HisP
and HisQ were equally resistant under pre- and post-hydrolysis conditions in the presence of arginine-loaded
solute-binding protein LAO and ATP/ADP. Some protection was also observed with LAO/arginine alone, thus
reﬂecting binding to the transporter in the apo-state and transmembrane signaling. Comparable digestion pat-
terns were obtained with the transporter reconstituted into proteoliposomes and nanodiscs. Fluorescence life-
time spectroscopy conﬁrmed the change of HisQ(R218) to a more apolar microenvironment upon ATP binding
and hydrolysis. Limited proteolysis was subsequently used as a tool to study the consequences of mutations on
the transport cycle. Together, our data suggest similar conformational changes during the transport cycle as de-
scribed for the maltose ABC transporter of Escherichia coli, despite distinct structural differences between both
systems.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
ATP-binding cassette (ABC) transporters are membrane proteins
that mediate the uptake or export of an enormous variety of substrates
at the expense of ATP. They are found in all organisms from bacteria to
man and dysfunction is often associated with disease [1]. Canonical ABC
import systems of prokaryotes are built up of two transmembrane do-
mains (TMD) forming a translocation path, a dimeric nucleotide binding
domain (NBD) that energizes the transport by hydrolysis of ATP, and an
extracellular high afﬁnity substrate-binding protein (SBP) [2,3]. By theirioxolo[4,5-f][1,3]benzodioxole;
idine tag; IPTG, isopropyl-β-D-
in; MOPS, (3-(N-morpholino)-
G, octyl-β-D-glucopyranoside;
protein; TMD, transmembrane
49 30 20938126.
chneider).
ights reserved.structure and size and due to biochemical analysis prokaryotic ABC im-
porters can be classiﬁed as type I and type II import systems [4].
As mechanism of transport, the “alternate access” model was pro-
posed based on biophysical and structural data [5–7]. Triggered by sig-
nals like SBP-binding, ATP-binding, ATP-hydrolysis, and ADP-release
which are transmitted over the TMDs by largely unknownmechanisms,
alternating inward- and outward-facing conformations are assumed
causing shuttling of the substrate to the cytoplasm (reviewed in Ref.
[8]). Although generally accepted, mechanistical variations are likely
to exist between type I and type II transporters. While the vitamin B12
importer Btu(CD)2, a type II importer, binds its cognate receptor, BtuF,
with high afﬁnity in its substrate-free form and in the absence of nucle-
otides, it loses afﬁnity upon ATP- or substrate binding [9]. The maltose
transporter, MalFGK2, as a representative of type I importers, on the
other hand seems to be associated with its solute binding protein,
MalE, throughout the transport cycle, howeverwithmuch lower afﬁnity
[10–12]. Themovements of the TMD aswell seem to result from oppos-
ing signals when comparing both systems [7,13,14]. These ﬁndings as
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porters of type I and type II, respectively [15], suggest that variations of
the mechanism and more experimental evidence from other systems
are required to clarify whether they go along with the classiﬁcation of
importers as type I and II. A ﬁrst exception from this notion was postu-
lated by Doeven et al. [16], who demonstrated by ﬂuorescence correla-
tion spectroscopy that the binding protein of the oligopeptide ABC
transporter of Lactococcus lactis, a type I importer, moved away from
themembrane components uponbinding of ATP to the ATPase subunits.
Furthermore, due to some unique features of the maltose transporter
[6], it is also questionable whether the derived transport model holds
for other type I ABC importers.
The type I histidine ABC transporter of Salmonella enterica serovar
Typhimurium (S. Typhimurium) is well characterized by biochemical
and biophysical means [17–20]. It consists of the transmembrane sub-
units HisQ and HisM, each spanning the lipid bilayer ﬁve times [21],
and a homodimer of the nucleotide-binding subunit, HisP. Substrates
are delivered by two solute binding proteins, HisJ with preference for
histidine, and LAO with highest afﬁnities for lysine, arginine and orni-
thine. While crystal structures of HisJ [22], LAO [23], and HisP [24] are
available, structural information on the complete transporter is elusive.
HisJ/LAO binds to HisQMP2 in unliganded and substrate-loaded form
with relatively low afﬁnity [25]. The opening and closing of the HisP2
dimer have been studied by ﬂuorescence spectroscopy and sulfhydryl
modiﬁcation [26] as well as by molecular dynamics simulations [27],
but little is known on conformational changes of the TMDs during the
transport cycle.
In this communication, limited proteolysis was used as a tool to
monitor conformational changes of the TMDs and NBDs of the histidine
transporter. This approach, supported by ﬂuorescence lifetime data,
provided further insights into the dynamics and signaling during the
catalytic cycle. Moreover it was proven useful in characterizing the con-
formational defects of transporter variants.
2. Material and methods
2.1. Bacterial strains, plasmids, and media
Strains and plasmids used in this study are summarized in Table 1.
Escherichia coli strain JM109 served as a host for general cloningTable 1
Bacterial strains and plasmids used in this study.
Strain or
plasmid
Relevant genotype
or description
Reference
or source
Escherichia coli strains
JM109 e14− (mcrA) recA1 endA1 gyrA96 thi-1 hsdR17
(r K−mK+) supE44 relA1 Δ(lac-proAB)
F′[traD36 proAB+ lacIq lacZΔM15]
Stratagene
(La Jolla, CA)
BL21 (DE3)
pLysS-T1R
F− ompT hsdSB(rB− mB−) gal dcm λ
(DE3) tonA pLysS (CmR)
Sigma Aldrich
(Germany)
Plasmids
Expression vectors
pET15b Apr, pT7lac, His6 coding sequence (5′),
thrombin cleavage site
Novagen
pET22b Apr, pT7lac, His6 coding sequence (3′) Novagen
argT*-hisJQMP plasmids of S. Typhimurium
pVE26 hisQMP on pET22b [30]
pSN3 argT on pET15b Lab collection
pVE27 hisQMP(T205A) on pET22b [46]
pJH5 hisQMP(E179Q) on pET22b This study
pJH26 hisQMP(R248H) on pET22b This study
pJH30 hisQMP(K254H) on pET22b This study
pJH31 hisQMP(K258H) on pET22b This study
pJH33 hisQ(R217H, R218H)MP on pET22b This study
pKB2 hisQ(R218C)*M*P* on pET22b This study
pJH42 hisP on pET22b This study
*The argT gene encodes the lysine/arginine/ornithine-binding protein LAO.purposes and strain BL21 (DE3) pLysS-T1R for overproduction of pro-
teins. Bacteria were usually grown in LB [28] or TB [29] medium,
supplemented with ampicillin (100 μg/ml) and/or chloramphenicol
(15 μg/ml) if required.
2.2. Site-directed mutagenesis and cloning of hisP
Mutagenesis of hisQMP was carried out using QuikChange Lightning
site-directed mutagenesis Kit (Stratagene, La Jolla, CA) according to the
manufacturer's instructions. Oligonucleotides were purchased from
Sigma Aldrich (Germany) and are listed in Table S1. Sequencingwas car-
ried out by SMB Services in Molecular Biology GmbH (Berlin, Germany).
The hisP wild type allele was cloned by PCR ampliﬁcation using
pVE26 (hisQMP) as template with oligonucleotides containing restric-
tion sites for subsequent ligation into a pET22b vector. The resulting
plasmid was named pJH 42 (Table 1).
2.3. Protein puriﬁcation
LAO-His6 was puriﬁed from the cytosolic fraction of E. coli strain BL21
(DE3) pLysS T1R harboring plasmid pSN3 bymetal-afﬁnity chromatogra-
phy on a TALON resin as described elsewhere [30,31]. The His-tag was
cleaved off by treatment with thrombin (Thrombin CleanCleave™ Kit,
Sigma-Aldrich, Germany) according to the manufacturer's instructions.
The proteinwas concentrated by a centrifugal device (Amicon,Millipore,
Germany) and buffered in 50 mMMOPS/K+ (pH 7.5), 5% (v/v) glyc-
erol, 0.15 M NaCl by passage through a PD10 desalting column (GE
Healthcare).
For overproduction and puriﬁcation of HisQM(P-His6)2 (wild type
and variants), E. coli strain BL21 (DE3) pLysS T1R was transformed with
pVE26 or its derivatives and grown in TB-ampicillin/chloramphenicol
to an OD650 of 0.8 prior to the addition of 0.1 mM IPTG. Cells were
harvested after overnight growth at 22 °C and the membrane fraction
was obtained by passage of cells through a French press and subsequent
ultracentrifugation (1.5 h at 200,000 × g). Membrane proteinswere sol-
ubilized by incubation with 1.1% DDM in the presence of 50 mMMOPS/
K+ (pH 7.5), 10% (v/v) glycerol, 0.1 mMPMSF for 1 h at 4 °C. After ultra-
centrifugation (1 h at 200,000 × g), HisQM(P-His6)2 was puriﬁed by
metal-afﬁnity chromatography using a TALON resin in the presence of
50 mM MOPS/K+ (pH 7.5), 10% (v/v) glycerol, 0.1 mM PMSF, 0.05%
DDM, 4 mM β-mercaptoethanol. After washing the resin with buffer in
the presence of 10 mM imidazole, protein was eluted with 100 mM im-
idazole. Protein-containing fractions were pooled, concentrated by a
centrifugal device (Amicon, Millipore, Germany) and buffered in
50 mM MOPS/K+ (pH 7.5), 20% (v/v) glycerol, 0.1 M NaCl, 0.02%
DDM by passage through a PD10 desalting column (GE Healthcare).
For puriﬁcation of HisP-His6 E. coli strain BL21 (DE3) pLysS T1R
harboring plasmid pJH42 was grown at 30 °C in LB-ampicillin/
chloramphenicol to an OD650 of 0.5 prior to the addition of 0.5 mM
IPTG, and harvested 3 h later. The cells were resuspended in 50 mM
MOPS/K+ (pH 7.5), 0.1 M NaCl, 0.1 mM PMSF and disintegrated by
ultrasonication. HisP-His6 was puriﬁed from the cytosolic fraction by
metal-afﬁnity chromatography on a TALON resin equilibrated in
50 mM MOPS/K+ (pH 7.5), 0.15 M NaCl, 5% (v/v) glycerol, 0.1 mM
PMSF. After binding and washing the resin with buffer supplemented
with 20 mM imidazole pH 8.0, protein was eluted with buffer contain-
ing 100 mM imidazole. Protein-containing fractions were pooled, con-
centrated by a centrifugal device (Amicon, Millipore, Germany) and
buffered in 50 mM MOPS/K+ (pH 7.5), 0.1 M NaCl, 10% (v/v) glycerol
by passage through a PD10 desalting column (GE Healthcare). Before
determination of protein concentration and trypsin digestion, the prep-
arationwas ultracentrifuged at 163,000 ×g for 30 min to remove aggre-
gated protein.
Protein concentration was determined using the BCA Kit of Uptima-
Interchim (France).
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Proteoliposomes containing HisQM(P-His6)2 or its variants were
essentially prepared as described in [30]. E. coli total lipids (Avanti
Polar Lipids) were dried in a rotating vacuum evaporator, redissolved
in 50 mM MOPS/K+ (pH 7.5), 1% OG to 20 mg/ml lipid, and sonicated
for 15 min. For subsequent ATPase activity assay, HisQM(P-His6)2
(50 μg) was mixed with 125 μl lipid solution and 50 mM MOPS/K+
(pH 7.5) to yield a ﬁnal volume of 300 μl. Proteoliposomeswere formed
by removal of detergent by adsorption to Biobeads (Bio-Rad, Germany)
at 4 °C overnight. After replacement with fresh Biobeads incubation
continued for 1 h. Proteoliposomes were recovered by ultracentrifuga-
tion for 30 min at 163,000 ×g, and resuspended in 50 mM MOPS/K+
(pH 7.5). For limited proteolysis, the proteoliposomes were resus-
pended in one third of the volume. The concentration and insertion
rate of the complex protein was determined by SDS gel electrophoresis
and pixel analysis.
2.5. Preparation of nanodiscs
Nanodiscs containing HisQM(P-His6)2 or its variants were essentially
prepared as described in [32] using tagless membrane scaffold protein
(MSP1E3D1) and E. coli total lipids (Avanti Polar Lipids). 8.3 mg lipid
was dried in a rotating vacuum evaporator and kept in an exsiccator
under vacuum overnight. Subsequently, the dried lipid ﬁlm was
resuspended in 900 μl 20 mM MOPS (pH 7.5), 0.1 M NaCl, DDM (87 μl
of a 10% solution) was added and the mixture was sonicated for 15 min
in a bathtype sonicator. Complex protein (1.8 mg), MSP (3.24 mg) and
the lipid preparation were mixed at a molar ratio of 1:8:960. Buffer was
added to reduce the glycerol concentration to below 3%, and themixture
was incubated at 4 °C for 1 h. Biobeads (1.5 mg) were added and the re-
constitution mixture was incubated at 4 °C for 4 h under gentle shaking.
Puriﬁcation of assembled nanodiscs with complex proteins was
performed by metal-afﬁnity chromatography using a TALON resin in
the presence of 50 mMMOPS/K+ (pH 7.5), 50 mM NaCl, thereby taking
advantage of the His6 tag at the C-terminal end of the HisP subunits. After
washing the resin with buffer in the presence of 25 mM imidazole, pro-
tein was eluted with 250 mM imidazole. Protein-containing fractions
were pooled, concentrated and buffered in 50 mM MOPS/K+ (pH 7.5)
by passage through a PD10 desalting column (GE Healthcare). The con-
centration was determined by pixel analysis following SDS PAGE. Since
two MSP molecules form a single nanodisc, an MSP to HisP ratio of 1:1,
as inferred by the pixel analysis, indicates that one HisQMP2 complex
was present per nanodisc (see Fig. 2B).
2.6. ATPase activity assay
ATPase activity was assayed essentially as described previously
[18,30]. Detergent-solubilized or reconstituted complex was preheated
for 3 min at 37 °C in the presence or absence of 0.4 mg/ml LAO and L-
arginine (1 mM). Reactions were started by the addition of ATP and
MgCl2 to yield a ﬁnal concentration of 2 and 10 mM (3 mM in case of
proteoliposomes or nanodiscs), respectively. Aliquots (25 μl) contain-
ing 4 μg detergent-solubilized or 2 μg reconstituted HisQM(P-His6)2
complex were taken over a time period of 4 min and mixed with 25 μl
12% sodium dodecyl sulfate (SDS) solution. The amount of phosphate
was determined colorimetrically, using Na2HPO4 as the standard.
2.7. Limited proteolysis
HisQM(P-His6)2 (3.6 μM) in detergent solution (50 mM MOPS/K+,
pH 7.5, 20% glycerol, 0.02% DDM, 0.1 M NaCl) or HisQM(P-His6)2
(3 μM) reconstituted in proteoliposomes or nanodiscs in 50 mM
MOPS/K+ (pH 7.5) or HisP-His6 (7.2 μM) in 50 mM MOPS (pH 7.5),
0.1 M NaCl, 10% glycerol were incubated in the absence and presence
of co-factors as indicated to reach ﬁnal concentrations of 10 mM ATP,10 mM ADP, 3 mM MgCl2, and 11 μM LAO/L-arginine (1 mM). The
samples were incubated for 20 min at 37 °C, followed by 10 min at
25 °C prior to the addition of trypsin (Sigma Aldrich, Germany) to
a ﬁnal concentration of 3 μM (long degradation assay) and 0.3 μM
(short degradation assay), respectively. Samples were taken at the indi-
cated time points, mixed with 10× SDS-PAGE sample buffer and shock
frozen in liquid nitrogen. Before loading of the samples onto the SDS
PAGE gel the samples were heated to 95 °C for 5 min. Quantitation of
the bands was done by pixel analysis with GelScan V5.0.
2.8. Mass spectrometry-based proteomic analysis
For nanoHPLC/ESI-MS/MS, an 1100HPLC system (Agilent)was used.
Separation was performed on a Zorbax 300 SB-C18 (150 mm × 75 μm;
Agilent) column with a Zorbax 300 SB-C18 (0.3 mm × 5 mm; Agilent)
enrichment column and a binarymobile phasewater/acetonitrile gradi-
ent with a maximum ﬂow rate of 0.30 μl/min. Peptides were separated
using a 35 min gradient. The eluents used were as follows: A, 94.9%
deionized water, 5% acetonitrile, 0.1% formic acid (v/v/v); and B, 99.9%
acetonitrile, 0.1% (v/v) formic acid. The separation column was coupled
to a Finnigan LTQ FT ULTRAmass spectrometer (Thermo Fisher Scientiﬁc,
Bremen, Germany) using a nanomate ESI interface (Advion) working
at 1.7 kV. Positive ionization and a transfer capillary temperature of
200 °C were applied. Product ions were detected in the FTICR cell and
collision induce dissociation (CID) was performed in the IonTrap with
data-dependent fragmentation and normalized collision energy of
35%. Proteome Discoverer 1.2 (Thermo) was used to analyze the data.
For the identiﬁcation the database uniprot and swissprot were chosen.
Identiﬁcation parameters: enzyme trypsin or chymotrypsin with 2
missed cleavages, modiﬁcations: deamidated (N), oxidation (M) and
propionamide (C), Tolerance: 5 ppm for the precursor mass tolerance
and 0.5 Da for the fragment mass tolerance. A reverse database was
used to prevent false positive identiﬁcation.
2.9. In-gel digestion
For in-gel digestion selectedprotein spotswere cut out, transferred to
vials, and washed three times using 200 μl (50% acetonitrile, and 50%
25 mM ammonium hydrogen carbonate (v/v)). Then the gel pieces
were dehydrated using 50 μl acetonitrile. The supernatant was removed
and the gel pieceswere dried for 20 min at 37 °C. 20 to 30 μl of modiﬁed
trypsin (0.01 g/l, Promega) in 25 mM ammonium hydrogen carbonate
or chymotrypsin (0.04 g/l, Sigma Aldrich) in 100 mM Tris–HCl (pH 8),
10 mM CaCl2 was added subsequently and after 30 min 20 μl of
25 mM ammonium hydrogen carbonate buffer was added to each vial;
trypsin and chymotrypsin digestion was carried out for 12 h at 37 °C.
After centrifugation, the supernatant was carefully removed, and the
peptideswere extracted twice from the gel by adding 50 μl of the follow-
ing extraction solution: 50% acetonitrile, 50% formic acid (5%). Finally all
pellets were extracted with 50 μl of acetonitrile. The supernatants were
pooled, evaporated to dryness by a vacuumconcentrator and redissolved
in 20 μl 0.1% formic acid (v/v) for analysis.
2.10. Fluorescence labeling and spectroscopy
For ﬂuorescence lifetime spectroscopy the single cysteine variant
HisQ(R218C)MP2was chemically labeledwith amaleimide taggedﬂuo-
rescent acyl [1,3] dioxolo[4,5-f] [1,3] benzodioxole (DBD) (compound
32) [33,34]. The puriﬁed protein in 50 mM MOPS/K+ (pH 7.5), 20%
(v/v) glycerol, 0.1 M NaCl, 0.02% DDM was incubated with a tenfold
molar excess of acyl-DBD-maleimide at 4 °C, overnight. Subsequently,
excess of ﬂuorescent dye was removed by size exclusion chromatogra-
phy using a PD10 column (GE Healthcare Life Sciences). The ﬂuores-
cence lifetime measurements were performed on a PicoQuant PDL 200
pulsed Laser Diode Fluorescence Lifetime Spectrometer. A 470 nm exci-
tation laser (PicoQuant)with 4 MHz repetition frequencywas used. The
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HisQ(R218C)M(P-His6)2 (2 μM) either in detergent solution (50 mM
MOPS/K+, pH 7.5, 20% glycerol, 0.02% DDM, 0.1 M NaCl) or embedded
into nanodiscs in 50 mM MOPS, pH 7.5, was analyzed in the absence
of co-factors and in the presence of ATP (10 mM) or ATP/MgCl2
(10 mM/3 mM), LAO (11 μM) and L-arginine (1 mM). Samples were
incubated for 20 min at 37 °C prior to spectroscopic analysis at 25 °C.
Five to seven measurements of each sample were recorded. The
resulting decays were ﬁtted with a three component model:
I tð Þ ¼
Zt
−∞
IRF t′
 X3
i¼1
Iie
t−t′
τi
dt′ ð3Þ
where Ii is the amplitude and τi is the lifetime of the i-th decay compo-
nent. The lifetime components were ﬁtted globally for each sample,
resulting in τ1 ~19 ns, τ2 ~7 ns and τ3 ~2 ns for detergent stabilized
and τ1 ~20 ns, τ2 ~7 ns and τ3 ~2 ns for reconstituted probes.
Amplitude-weighted lifetimes for single curve ﬁttings were calculated,
averaged for each catalytical state and represented asmean ± standard
deviation.
3. Results
3.1. Discrete conformations of HisQM(P-His6)2 can be visualized by limited
proteolysis
In order to study conformational changes of the histidine transporter
during the transport cycle, we used limited proteolysis with two differ-
ent trypsin concentrations and incubation times, resulting in slow
(Fig. 1A and B) and fast appearing degradation products (Fig. 1C and
D). Three conditions of the transporter were monitored: the apo-state
in plain buffer, the ATP-bound state, and the hydrolysis state which
was obtained by the addition of MgATP and LAO/arginine.
In the long degradation assay (incubationwith 3 μM trypsin for up to
8 min) the following observationsweremade (Fig. 1A andB): (i) HisP2 is
digested to a slightly smaller polypeptide, named P1, the occurrence of
which is dependent on the state of the transport cycle. HisP2 is most sus-
ceptible in the apo-state,while ATP-binding signiﬁcantly slows down the
rate of degradation. In the hydrolysis state only about one third of the di-
gestion product is found compared to the ATP-bound state.
To exclude that degradation of HisPmight at least in part be due to an
excess of soluble HisP that is not associatedwith HisMQ, limited proteol-
ysis was also performedwith puriﬁed soluble HisP2 under the same con-
ditions as described above. Additionally, LAO/arginine was added to the
ATP-bound state and also the MgADP-bound state was monitored. The
digestion pattern shows (Fig. S1) that in the apo-state full length
HisP2 is almost completely degraded resulting in prominent peptide
fragments b 20 kDa. Since these fragments are absent in the HisQMP2
digestion pattern (Fig. 1A, lane 2), we conclude that the complex prepa-
ration contains if at all only negligible amounts of freeHisP2. The addition
of nucleotide and Mg2+ ions has some stabilizing effect on HisP2 as also
observedwith HisQMP2 (Fig. 2A and B) suggesting that this effect occurs
independently of HisQM but solely due to the closure of the HisP dimer
thereby rendering the respective cleavage sites less susceptible. As
expected, the addition of LAO had no effect on the digestion pattern
conﬁrming that binding of LAO is signaled through HisQM to the NBDs.
(ii) HisQ is degraded to fragment Q1 and subsequently Q2. Also this
degradation is dependent on the state of the transporter, with
Q1 being more stable in the hydrolysis state.
(iii) HisM is gradually degraded under all conditions tested up to
8 min of incubationwith trypsin but a stable fragment could nei-
ther be detected by Coomassie staining nor by immunoblotting
using an antiserum raised against the C-terminal peptide of
HisM (F221-K235) (not shown).In the short degradation assay (0.3 μM trypsin for up to 60 s) HisP
and HisM appear to be stable (Fig. 1C and D). HisQ, on the other hand,
is degraded to the slightly smaller fragment Q1, again very fast in the
apo-state, more slowly in the ATP-bound form, and even more stabi-
lized in the hydrolyzing complex. Fragment Q2 is not generated under
these conditions.
To test if after trypsin degradation the subunits still form a complex
despite the loss of part of HisQ, an aliquot was subjected to metal-
afﬁnity chromatography using a Talon resin (see Material and methods
for details) directly after digestion. The result shows that mature HisP
andHisM co-elutewith fragment Q1 suggesting a stably assembled com-
plex (Fig. S2).
It should be noted that LAO is completely stable under all conditions.
LAO was given preference over HisJ because in contrast to the latter, it
does not comigrate with fragment P1 in the SDS gel.
3.2. Conformational changes are also observed in a lipid environment
The above results indicated conformational changes of the trans-
porter subunits especially under conditions of ATP hydrolysis, i.e. in
the presence of LAO/arginine. However, in contrast to the transporter
incorporated into proteoliposomes, LAO/arginine-stimulated ATPase
activity is not observed in detergent solution [35] (Table 2). Thus, to in-
vestigate the effect of a lipid environment on the proteolytic cleavage
pattern,we repeated key experimentswith proteoliposomes containing
HisQMP2.
As shown in Fig. 2A, basically the same cleavage pattern and co-
factor dependent protection against the protease under slow degrada-
tion conditions was observed as in detergent solution. The proﬁle
concerning HisP/P1 is less pronounced than in detergent solution prob-
ably because roughly only half of the transporter is oriented in the lipid
bilayer with HisP2 exposed to the medium and thereby accessible for
the protease [36]. The observation that in the hydrolytic complex, bind-
ing of externally added LAO is protecting HisP despite the juxtaposing
orientation can be explained by the presence of Mg2+ ions which
make the vesicles leaky for ATP and substrate and even for small pro-
teins [35]. An interesting feature is the stable accumulation of fragment
Q2 compared to detergent solution (see Fig. 1A). This might be due to a
putative cleavage site within Q2which is not exposed to the protease in
the lipid environment.
Due to the described inherent feature of proteoliposomes that trans-
porter molecules are incorporated in two orientations and thus, only
half of the potential tryptic cleavage sites are exposed to the medium,
no clear patternwas obtained under fast degradation conditions. Conse-
quently, we performed limited proteolysis with the transporter embed-
ded in lipid nanodiscs [37]. Nanodiscs are composed of a phospholipid
bilayer domain with two copies of an amphipathic membrane scaffold
protein (MSP) that wrap around the periphery of the bilayer. They
form by removal of detergent from initial detergent-phospholipid mi-
celles. When a membrane protein is added it is trapped within the
forming nanodisc structure. The advantage over proteoliposomes lies
in the accessibility of the membrane protein from both sides of the
bilayer.
Care has of course to be taken that the MSP itself is not cleaved by
trypsin under the assay conditions. Kinetic analysis however revealed
that the protein was fully stable up to 60 s (Fig. S3).
Fig. 2B illustrates that basically the same cleavage pattern and co-
factor dependent protection against theprotease is observed innanodiscs
as in detergent solution, albeit less pronounced. In the apo-state, some
undigested HisQ is still detectable, which might be due to less ﬂexible
polypeptide chains in a lipid environment and thus reduced susceptibility
to the protease. This notion is consistent with the results of a recent EPR
analysis of the histidine transporter (Sippach,Weidlich, Klose, Schneider,
Steinhoff, unpublished) and ﬁndings for members of other transporter
families [38]. However, clear protection of HisQ against tryptic digestion
as found in detergent solution (Fig. 1C and D) is also observed in
Fig. 1. Limited proteolysis ofwild typeHisQMP2 in the absence and presence of co-factors.Wild type HisQMP2 in detergent solutionwas incubated in the absence of co-factors, in the presence of ATP, and during hydrolysis. Trypsinwas added to a ﬁnal
concentration of 3 μM (A) or 0.3 μM (C). Samples were taken at indicated times and subjected to SDS-PAGE. See ‘Material and methods’ for further details. Quantitation of mature proteins and cleavage products was carried out by pixel analysis of
Coomassie-stained SDS gels from three independent experiments with Gelscan Standard V5.0 software. The units given are amounts of protein at the indicated time points relative to time point 0 of the degradation reaction. B. HisP/P1. D. HisQ/Q1.
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Fig. 2. Trypsin digestion pattern of HisQMP2 in proteoliposomes and nanodiscs. HisQMP2 was incorporated in proteoliposomes (A) or nanodiscs (B) to a concentration of 3 μM. LAO was
added to the reactionmix to a concentration of 10 μMin the presence of 1 mMarginine. Limitedproteolysiswas essentially performed as described in the legend to Fig. 1. See ‘Material and
methods’ for further details.
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ditions. Faint protein bands appearing above HisM which probably de-
rived from HisP were not further analyzed because no reproducible
pattern could be obtained. Together, we conclude that digestion patterns
observed in detergent solution are also detectable when the transporter
is embedded in a lipid bilayer.Table 2
ATPase activities of histidine transporter variants.
Variant
protein
LAO/
arginine
ATPase activity
(μmol Pi min−1 mg−1)
Stimulation by LAO/
arginine
(n-fold)
Detergent solution
HisQMP2 wild type − 0.097 ± 0.032 −
+ 0.096 ± 0.005
HisQMP(E179Q)2 − 0.0090 ± 0.0014 −
+ 0.0014 ± 0.0069
HisQMP(T205A)2 − 0.645 ± 0.124 −
+ 0.540 ± 0.073
HisQMP(K258H)2 − 0.057 ± 0.010 −
+ 0.084 ± 0.012
HisQ(R217H, R218H)MP2 − 0.054 ± 0.010 −
+ 0.051 ± 0.008
HisP2 − 0.025 ± 0.004 n.a.
Proteoliposomes
HisQMP2 wild type − 0.119 ± 0.01 4.25
+ 0.698 ± 0.03
HisQMP(E179Q)2 − 0.025 ± 0.021 −
+ 0.005 ± 0.012
HisQMP(T205A)2 − 3.027 ± 0.158 −
+ 2.968 ± 0.182
HisQMP(K258H)2 − 0.380 ± 0.025 2.97
+ 1.129 ± 0.067
HisQ(R217H, R218H)MP2 − 0.320 ± 0.032 3.13
+ 1.003 ± 0.052
HisQ(R218C)M*P*2 − 0.040 ± 0.003 6.22
+ 0.249 ± 0.008
HisQ(R218C-32)M*P*2 − 0.115 ± 0.013 2.47
+ 0.284 ± 0.009
Nanodiscs
HisQMP2 wild type − 0.160 ± 0.041 3.2
+ 0.512 ± 0.091
HisQ(R218C-32)M*P*2 − 0.036 ± 0.001 4.03
+ 0.145 ± 0.007
SE mean (n ≥ 3). * denotes cys-less variant; n.a., not applicable.3.3. Identiﬁcation of proteolytic fragments and cleavage sites by mass spec-
trometry and mutational analysis
To identify the tryptic cleavage sites resulting in the observed pro-
teolytic fragments of HisP and HisQ, stained protein bandswere excised
from gel slices and analyzed by mass spectrometry. Fragments P1, Q1
and Q2 were veriﬁed as derived from HisP and HisQ, respectively
(Fig. 3A). While Q1 and P1 resulted from cutting off rather short pep-
tides, Q2 seems to encompass the core helices 2, 3 and 4. Interestingly,
once formed, this core region is very stable in a lipid environment and
less stable in detergent solution, indicating that it is well buried in the
lipid bilayer (Fig. 2A).
Trypsin cleaves proteins at the C-terminal end of arginine and lysine
residues. Sincemass spectrometry does not necessarily cover all peptides
derived from trypsin digestion, peptides located N- or C-terminally
might not be detected and thus, both ends of the fragments cannot be
determined with accuracy as long as there are additional lysines or argi-
nines present. Therefore, all the potential cleavage sites for P1 and Q1
were mutated to histidines in the hisP and hisQ genes, followed by puri-
ﬁcation of the respective transporter variants. Subsequently, trypsin di-
gestion was performed under conditions, where the fragments were
found to be most abundant (P1: 8 min/3 μM trypsin/apo-state; Q1:
60 s/0.3 μM trypsin/apo-state). The immunoblot (for HisP/P1) and SDS
gels (for HisP/P1 and HisQ/Q1) for those mutants that displayed resis-
tance to trypsin (Fig. 3B) demonstrate that HisP is cleaved at a low
ratio C-terminally of arginine 248 and lysine 254 but cleavage is
completely suppressed when lysine 258 is mutated (Fig. 3B, left panel).
Thus, all three sites are apparently susceptible to trypsin but the most
distal (C-terminal) lysine, immediately preceding the His tag, is the pre-
ferred cleavage site in HisP (Fig. 3C, left panel). In the case of HisQ, one or
both arginines at positions 217/218 are the recognition sites for trypsin
since cleavage is no longer observed aftermutating these residues to his-
tidines (Fig. 3B and C, right panel). (Please note that the mutations
caused HisQ to migrate faster in the SDS gel.) Measuring ATPase activity
of the complex variants in detergent solution and reconstituted in
proteoliposomes assured that the mutations did not affect transporter
function (not shown). The possible cleavage site(s) resulting in fragment
Q2 were not further veriﬁed since compared to Q1 it was less indicative
for deﬁned states of the transport cycle.
Both conﬁrmed main cleavage sites are located close to the respec-
tive C-terminal ends of the proteins as shown in a homology model of
HisQMP2 [39] which is based on the crystal structure of the E. coli
Fig. 3. Identiﬁcation of the tryptic cleavage fragments and their cleavage sites by mass spectrometry and mutational analysis. A. Fragments P1, Q1, and Q2 were excised from the
Coomassie-stained SDS gel and analyzed by mass spectrometry following total digestion with trypsin (P1, Q2) or chymotrypsin (Q1) digestion. Identiﬁed fragments are highlighted in
red. B. Limited proteolysis of potential cleavage site mutants under slow (HisP, left panel) and fast (HisQ; right panel) degradation conditions analyzed by SDS-PAGE and immunoblotting
(HisP only). C. Location of the conﬁrmed cleavage sites (in ball-and-stick presentation) is shown in the homology model of HisQMP2 (P-K258) and HisQM (Q-R217, Q-R218). HisP2 is
shown in green, HisM in blue and HisQ in brown. Fragment HisQ2 is indicated in red in the HisQMmodel (right panel).
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virtually the His-tag is removed by trypsin after the ﬁnal helix which
probably interacts with the opposing HisP monomer.
3.4. HisP and HisQ are most protected against trypsin during hydrolysis
Since the results described above proved the suitability of limited
proteolysis to detect distinct conformations of the transporter, we inves-
tigated cofactor-dependent cleavage pattern in more detail. To this end,
degradation of HisP was analyzed under long degradation conditions
(3 μM trypsin/8 min) with the detergent solubilized complex while
short degradation conditions (0.3 μM trypsin/60 s) to study the fate of
HisQ were applied to the transporter both in detergent micelles and in
nanodiscs. As shown in Fig. 4, the following conclusions can be drawn:
HisP is most stabilized under hydrolytic and post-hydrolytic conditions,
e.g. in the presence of LAO/arginine, Mg2+ ions and ATP or ADP (Fig. 4A
and B, lanes 4 and 5). A similar protective effect is observed with ATP in
the presence of LAO/arginine, representing the pre-hydrolysis state
(Fig. 4A and B, lane 3). Under the latter conditions and in analogy to
what was found for the maltose transporter [12,40–42], the HisP dimeris supposed to be fully closed while upon ATP hydrolysis the transporter
is thought to reside in a semi-open state. Thus, the extremeC-terminus of
HisP changes conformation during catalysis, being less exposed to the
medium in the pre-, post- and hydrolytic state. Interestingly, already
binding of arginine-loaded LAO caused some protection of HisP against
trypsin (Fig. 4A and B, lane 7), thus communicating the availability of
substrate across the membrane to the NBDs. This observation is consis-
tent with results of a previous study using far-UV CD spectroscopy to
demonstrate secondary structural changes of the histidine transporter
in the presence of HisJ only [26].
Similar results were obtained for HisQ. While in the apo-state (no
cofactors added), HisQ was completely converted to Q1 (Fig. 4C and D,
lane 1), under hydrolytic and post-hydrolytic conditions, the amount
of HisQ was 2-3fold higher than that of Q1 (Fig. 4C and D, lane 5). Con-
sequently, residues Arg-217 and Arg-218 are protected against proteo-
lytic attack, suggesting a motional change of helix 5 upon ATP
hydrolysis. In the presence of LAO/arginine only (Fig. 4C and D, lane
7), the amount of Q1 was in between that of the apo- and hydrolytic
states, similar to what was observed for P1. Thus, LAO is able to bind
to the transporter in the apo-state, thereby provoking a change in
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formation of the TMDs half way from inward- to outward-facing. In the
presence of LAO/arginine and ATP, representing the pre-hydrolytic
state (Fig. 4C and D, lane 3), the cleavage pattern resembles that of the
hydrolytic and post-hydrolytic state (lanes 4 and 5), although HisQ was
overall more susceptible to trypsin.
In agreement with these results, the digestion of HisQ when ana-
lyzed in nanodiscs is most limited under pre-hydrolytic conditions
(Fig. 4E and F, lane 4) and during hydrolysis (Fig. 4E and F, lane 5).
Thus, motional changes of the TMDs as observed in detergent solution
are basically reﬂecting those in a lipid environment.
Together, these results indicate that there are differentially suscepti-
ble cleavage sites in the NBDs and TMDs allowing the detection of a va-
riety of conformers, presumably going along with open, semi-closed
and closed states of the transporter during the cycle. Interestingly, sim-
ilar experimentswith themaltose transport complex showed a different
pattern: the TMDs and MalFG were more protected in the apo-state
than in the ATP-bound complex or post-hydrolytic state [43]. This is
explainable by the location of the respective cleavage sites in the large
periplasmic loops P1 and P2 of MalG and MalF, respectively, which are
absent in HisQM. These loops are apparently more exposed to the sol-
vent when the NBDs (MalK2) reside in the closed (ATP-bound) confor-
mation. In particular, this might coincide with the observation that
MalF-P2 undergoes a conformational change upon concomitant binding
of substrate-loaded binding protein and ATP [44].
3.5. Fluorescence lifetime spectroscopy conﬁrms motional changes of HisQ
The proteolysis data revealed reduced susceptibility of the tryptic
cleavage site of HisQ (R217/R218) (Fig. 3C, right panel) located at the
cytoplasmic side of the membrane upon ATP binding and hydrolysis.
This ﬁnding indicates a reorientation of transmembrane helix 5 during
the translocation cycle. To obtain further proof for this notion, we
performed ﬂuorescence lifetime spectroscopy with a transporter vari-
ant containing a cysteine residue at position 218 of HisQ, thus allowing
site-speciﬁc labeling with the ﬂuorophore acyl-DBD-maleimide. DBD
dyes are ﬂuorescent probes which can be used to sense even small po-
larity changes since their ﬂuorescence lifetime is highly inﬂuenced by
the polarity of their microenvironment [33,34]. Fig. 5 presents the aver-
age amplitude weighted ﬂuorescence lifetimes (τAV) of acyl-DBD la-
beled HisQ(R218C)MP2 in detergent solution and after reconstitution
in nanodiscs. The mean lifetimes for detergent stabilized trans-
porters were 6.2 ns in the apo-state, 6.5 ns the in ATP-bound sate
and 6.6 ns under hydrolyzing conditions. The mean lifetimes for
nanodisc reconstituted transporters analyzed under the same condi-
tions were 5.7, 6.1 and 6.3 ns, respectively. Hence, the ﬂuorescence
spectroscopy results are conﬁrming discrete conformational states
of the transporter as found by limited proteolysis. As indicated by an in-
crease in ﬂuorescence lifetime of the dye, HisQ(R218) is exposed to a less
polar environment upon binding of ATPwhich is evenmore pronounced
after ATP hydrolysis. Possibly, these changes may be explained by exclu-
sion of watermolecules from the local environment of the residue. Inter-
estingly, the increase in ﬂuorescent lifetime from apo- to ATP-bound
state in nanodiscs is more than twice as high (Δτ = 0.3–0.4 ns) as the
lifetime increase from ATP-bound to hydrolysis state (Δτ = 0.1–
0.2 ns). This displays a larger change upon ATP binding in comparison
to that of ATP hydrolysis and is also consistent with the ﬁndings from
limited proteolysis (e.g. compare lanes 1, 2 and 4 in Fig. 4C). The higher
absolute values of ﬂuorescent lifetime in the case of detergent stabilizedFig. 4. Limited proteolysis of HisQMP2 under various conditions. Limited proteolysis was
performed with complex protein in detergent micelles (A, C) or embedded in nanodiscs
(E) in the absence or presence of co-factors as indicated. Protein samples were taken at
time points 0 (control), 8 min (HisP) (A) or 60 s (HisQ) (C, E), subjected to SDS-PAGE
and the resulting fragments P1 (B) and Q1 (D, F) were subsequently quantiﬁed relative
to the mature proteins by pixel analysis as described in the legend of Fig. 1. See ‘Material
and methods’ for further details. Co, control. Representative gels are shown.
Fig. 5. Fluorescence lifetime spectroscopy of DBD-HisQ(R218C)MP2. The amplitude
weighted ﬂuorescence lifetime averages of DBD-labeled HisQ(R218C)MP2 with standard
deviation (28 measurements in detergent solution, 10 measurements in nanodiscs) are
shown in different states of the transport cycle. The average lifetime increases upon ATP
binding and hydrolysis for both, detergent stabilized and nanodisc-reconstituted DBD-
HisQ(R218C)MP2. See ‘Material and methods’ for details. The data were analyzed using a
Mann–Whitney U-test (p b 0.001 = ***, p b 0.01 = **, p b 0.05 = *).
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microenvironments after reconstitution. Nevertheless, the same envi-
ronmental changes have been observed for the transporter both in deter-
gentmicelles and embedded in nanodiscs, thus strongly suggesting again
that the properties of the histidine transporter in detergent solution re-
ﬂect those in a lipid environment.Fig. 6. Tryptic digestion proﬁles of histidine transporter variants. The indicated variants
were subjected to limited proteolysis under slow (HisP) (A) and fast (HisQ) (C) degrada-
tion conditions in the absence and presence of co-factors as indicated. Quantitation of frag-
ments following SDS-PAGE (B, D) was performed as described in the legend of Fig. 1.3.6. Proteolytic digestion patterns of complex variants display deviations
from wild type
Having established limited proteolysis as a tool to detect distinct
conformations of the histidine transporter during the transport cycle,
we set out to apply the technique to transporter variants with different
phenotypes: (i) TheHisQMP(E179Q)2 variant ismutated in the catalytic
carboxylate whose function is to orient the water molecule which is
attacking the γ-phosphate of ATP [24]. Therefore this mutant, like the
analogous mutant (MalK-E159Q) of the maltose transport system
[6,45], binds ATP while not being able to hydrolyze it. Moreover, in
the crystal structure of the respective maltose transporter mutant, sub-
strate was already released to its binding site in the MalF subunit and,
consequently, the binding protein was found in its open conformation.
Thus, it is assumed to represent a catalytic intermediate [6]; (ii) the
HisQMP(T205A)2 mutant was described earlier as binding protein-
independent variant with high intrinsic ATPase activity that is coupled
to transport [46,47], although further activation was observed in the
presence of HisJ/histidine, suggesting that SBP can still interact with
the complex. Themutantswere puriﬁed and analyzed for their expected
ATPase activities in detergent solution and in proteoliposomes, which
conﬁrmed the described phenotypes (Table 2). Fig. 6 shows the results
of limited proteolysis performed with the variants under slow and fast
degradation conditions.
TheATPase-deﬁcientmutantHisQM(P-E179Q)2 exhibitedhigher re-
sistance of HisP and HisQ against trypsin compared to wild type under
all conditions, but being most resistant in the absence of co-factors.
This ﬁnding is consistent with the notion that the mutant's NBDs are
locked in the closed conformation mimicking the ATP-bound state [6].
Our results demonstrate that this conformation also affects the relative
exposure of helix 5 of HisQ. Furthermore, under conditions promoting
hydrolysis, although ATP is not hydrolyzed by the mutant, stabilization
of HisP and HisQ is more comparable to wild type indicating that bind-
ing of LAO is still signaled to the cytoplasmic side of the complex. The
ﬁndings for E179Qmatch the results of limited proteolysis and crosslink
studieswith themaltose transporter [43,45] and are consistent with the
crystal structure of MalE-FGK(E159Q)2 [6].In contrast, the binding protein-independent mutant HisQMP
(T205A)2 generally displayed higher susceptibility of HisP to trypsin, es-
pecially in the apo-state, suggesting a less stable overall structure. This
ﬁnding is in line with the previous notion that the T205Amutation ren-
ders the transport complex more ﬂexible [47] resulting e.g. in partial
uncoupling from activating stimuli like binding of the SBP [48]. Interest-
ingly, this phenotype is not seen with HisQ that exhibits normal overall
stability but nevertheless also lacks a typical apo-state conformation,
probably because the inward-facing conformation of the TMDs depends
on the open conformation of the NBDs.4. Discussion
We have demonstrated that limited proteolysis is a suitable tool to
unravel conformational changes of HisQMP2 in different states of the
ATPase/transport cycle. One and two transiently stable cleavage frag-
ments of HisP and HisQ, respectively, were observed, of which P1 and
Q1 could be precisely identiﬁed. The cleavage sites have no functional
relevance and are localized close to the carboxy-terminal ends of both
subunits.
The C-terminal domain of HisP is short compared to the NBDs of e.g.
the maltose or methionine transporters whose C-terminally extended
peptide regions have additional regulatory functions [49,50]. In the
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terminal helices of the NBD dimers intertwine with each other and
probably do not separate during ATP binding/hydrolysis but tilt around
a hinge at the C-terminus [5]. Possibly, the C-terminal helices of HisP
form a similar hook-like fold and such a twist makes the lysine 258 in
HisP differentially susceptible to trypsin. In HisQ the last (5th) helix
which probably extends into the cytoplasm is cleaved at one or both
of the arginines which are surface exposed according to the structural
model. Since the cleavage site is exposed in the apo-state but more
concealed in the ATP-bound complex and in the hydrolytic complex,
our results from limited proteolysis and ﬂuorescence lifetime spectros-
copy might indicate reorientation of helix 5 of HisQ and/or a closer
packing of the complex protein uponNBD dimer closure. Results of a re-
cent EPR study also point to a reorientation of helices within HisQM
rather than a simple unidirectional opening–closing event of the two
halves of the transporter (Sippach,Weidlich, Klose, Schneider, Steinhoff,
unpublished data). Sequence alignment of helix 5 of HisQ with C-
terminal peptides of not only closely related proteins but also including
MetI and ModB, revealed, with two exceptions, conservation of at least
one positively charged residue homologous to HisQ-R218 next to a glu-
tamate or aspartate (Fig. S4). Moreover, in the C-terminal helix of MalG,
an arginine residue (R283) is present which in the crystal structures of
the maltose transporter in the apo- (PDB ID: 3FH6) and pre-hydrolysis
state (PDB ID: 2R6G) is exposed to the medium. Although these data
imply that, in contrast to HisQ, the carboxy-terminal helix of MalG
does not change conformation upon binding of ATP and MalE/maltose,
a tryptic fragment similar to Q1 was not obtained [43]. Rather, a cleav-
age site in periplasmic loop P1 was identiﬁed in MalG, indicating that
the mobility of the helix in detergent solution differs from what is ob-
served in the crystal structure. Interestingly, two arginine residues are
also present at homologous positions of the HisM subunit. Since no
cleavage products corresponding to Q1 and Q2 were obtained, our
data suggest a different conformation of the C-terminal peptide of
HisM compared to HisQ. Trypsin digestions with the closely related ar-
ginine transporter Art(MP)2 suggest similar cleavage sites in the TMD
ArtM and the NBD ArtP [39]. Here, ArtP is also more protected in pre-
hydrolytic and hydrolytic state, indicating comparable motional
changes. ArtM cleavage shows nodifferential pattern upon ATP/SBP-ad-
dition/hydrolysis what again points to different conformations/move-
ments of the C-terminal helix of the TMDs of different transporters
provided that the trypsin cleavage site is homologous to HisQ(R217/
R218) [39]. The cleavage pattern of HisQMP2 clearly allowed to distin-
guish the apo-state from the pre-, post-, and hydrolytic states while
conformational changes triggered by ATP hydrolysis are apparently
not accompanied by a change in exposure of the cleavage sites to the
protease. Moreover, increased resistance of HisP2 and HisQ to trypsin
in the presence of liganded LAO reﬂects transmembrane signaling as ob-
served for the maltose transport complex [43,44]. Moreover, the trans-
porter variants exhibit differential proteolytic pattern explaining and
conﬁrming their deviant characteristics.
Together, despite the structural differences between the maltose
and histidine transporters, our data suggest similar conformational
changes during the transport cycle.
Acknowledgements
We thank Heidi Landmesser and Gabriele Brune (both from Hum-
boldt Universität zu Berlin) for excellent technical assistance. This
work was supported by the Deutsche Forschungsgemeinschaft (PAK
459, SCHN 274/14-1 to E.S. and PAK 459/2 - HE 3763/13-2 to A.H.).
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2013.08.024.References
[1] In: E.B. Holland, S. Cole, K. Kuchler, C.F. Higgins (Eds.), ABC Proteins: From Bacteria
to Man, Elsevier, Amsterdam, 2003.
[2] A.L. Davidson, E. Dassa, C. Orelle, J. Chen, Structure, function, and evolution of ATP
binding cassette systems, Microbiol. Mol. Biol. Rev. 72 (2008) 317–364.
[3] T. Eitinger, D.A. Rodionov, M. Grote, E. Schneider, Canonical and ECF-type ATP bind-
ing cassette importers in prokaryotes: diversity inmodular organization and cellular
functions, FEMS Microbiol. Rev. 35 (2011) 3–67.
[4] K. Locher, Structure and mechanism of ATP-binding cassette transporters, Philos.
Trans. R. Soc. Lond. B Biol. Sci. 364 (2009) 239–245.
[5] K. Hollenstein, D.C. Frei, K.P. Locher, Structure of an ABC transporter in complexwith
its binding protein, Nature 446 (2007) 213–216.
[6] M.L. Oldham, D. Khare, F.A. Quiocho, A.L. Davidson, J. Chen, Crystal structure of a cat-
alytic intermediate of the maltose transporter, Nature 450 (2007) 515–522.
[7] D. Khare, M. Oldham, C. Orelle, A.L. Davidson, J. Chen, Alternating access in maltose
transporter mediated by rigid-body rotations, Mol. Cell 33 (2009) 528–536.
[8] A. Licht, E. Schneider, ATP binding cassette systems: structures, mechanisms, and
functions, Cent. Eur. J. Biol. 6 (2011) 785–801.
[9] O. Lewinson, A.T. Lee, K.P. Locher, D.C. Rees, A distinct mechanism for the ABC trans-
porter BtuCD-BtuF revealed by the dynamics of complex formation, Nat. Struct. Mol.
Biol. 17 (2010) 332–338.
[10] M.L. Daus, S. Berendt, S. Wuttge, E. Schneider, Maltose binding protein (MalE) inter-
acts with periplasmic loops P2 and P1 respectively of theMalFG subunits of the malt-
ose ATP binding cassette transporter (MalFGK(2)) from Escherichia coli/Salmonella
during the transport cycle, Mol. Microbiol. 66 (2007) 1107–1122.
[11] M.L. Daus, M. Grote, E. Schneider, TheMalF P2 loop of the ATP-binding cassette trans-
porter MalFGK2 from Escherichia coli and Salmonella enterica serovar Typhimurium
interacts with maltose binding protein (MalE) throughout the catalytic cycle, J.
Bacteriol. 191 (2009) 754–761.
[12] S. Böhm, A. Licht, S. Wuttge, E. Schneider, E. Bordignon, Conformational plasticity of
the type Imaltose ABC importer, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 5492–72013.
[13] B. Joseph, G. Jeschke, B.A. Goetz, K.P. Locher, E. Bordignon, Transmembrane gate
movements in the type II ATP-binding cassette (ABC) importer BtuCD-F during nu-
cleotide cycle, J. Biol. Chem. 286 (2011) 41008–41017.
[14] V.M. Korkhov, S.A. Mireku, K.P. Locher, Structure of AMP-PNP-bound vitamin B(12)
transporter BtuCD-F, Nature 490 (2012) 367–372.
[15] E. Vigonsky, E. Ovcharenko, O. Lewinson, Two molybdate/tungstate ABC trans-
porters that interact very differently with their substrate binding proteins, Proc.
Natl. Acad. Sci. U. S. A. 110 (2013) 5440–5445.
[16] M.K. Doeven, G. van den Bogaart, V. Krasnikov, B. Poolman, Probing receptor-
translocator interactions in the oligopeptide ABC transporter by ﬂuorescence corre-
lation spectroscopy, Biophys. J. 94 (2008) 3956–3965.
[17] G.F. Ames, Bacterial periplasmic transport systems: structure, mechanism, and evo-
lution, Annu. Rev. Biochem. 55 (1986) 397–425.
[18] G.F.-L. Ames, K. Nikaido, I.X. Wang, P.-Q. Liu, C.E. Liu, C. Hu, Puriﬁcation and charac-
terization of the membrane-bound complex of an ABC transporter, the histidine
permease, J. Bioenerg. Biomembr. 33 (2001) 79–92.
[19] E. Schneider, Import of solutes by ABC transporters-the maltose and other systems,
in: ABC proteins: From bacteria to man, (E.B. Holland, S. Cole, K. Kuchler, C. Higgins,
eds), 2003, pp. 157–185.
[20] E. Schneider, V. Eckey, D. Weidlich, N. Wiesemann, A. Vahedi-Faridi, P. Thaben, W.
Saenger, Receptor-transporter interactions of canonical ATP-binding cassette import
systems in prokaryotes, Eur. J. Cell Biol. 91 (2012) 311–317.
[21] R.E. Kerppola, G.F. Ames, Topology of the hydrophobic membrane-bound compo-
nents of the histidine periplasmic permease. Comparison with other members of
the family, J. Biol. Chem. 267 (1992) 2329–2336.
[22] B.H. Oh, C.H. Kang, H. de Bondt, S.H. Kim, K. Nikaido, A.K. Joshi, G.F. Ames, The bac-
terial periplasmic histidine-binding protein. Structure/function analysis of the
ligand-binding site and comparison with related proteins, J. Biol. Chem. 269
(1994) 4135–4143.
[23] C.H. Kang, W.C. Shin, Y. Yamagata, S. Gokcen, G.F. Ames, S.H. Kim, Crystal structure of
the lysine-, arginine-, ornithine-binding protein (LAO) from Salmonella typhimurium
at 2.7-Å resolution, J. Biol. Chem. 266 (1991) 23893–23899.
[24] L.W. Hung, I.X. Wang, K. Nikaido, P.Q. Liu, G.F. Ames, S.H. Kim, Crystal structure of
the ATP-binding subunit of an ABC transporter, Nature 396 (1998) 703–707.
[25] G.F. Ames, C.E. Liu, A.K. Joshi, K. Nikaido, Liganded and unliganded receptors interact
with equal afﬁnity with the membrane complex of periplasmic permeases, a sub-
family of trafﬁc ATPases, J. Biol. Chem. 271 (1996) 14264–14270.
[26] D.I. Kreimer, K.P. Chai, G.F. Ames, Nonequivalence of the nucleotide-binding sub-
units of an ABC transporter, the histidine permease, and conformational changes
in the membrane complex, Biochemistry 39 (2000) 14183–14195.
[27] J.D. Campbell, S.S. Deol, F.M. Ashcroft, I.D. Kerr, M.S.P. Sansom, Nucleotide-dependent
conformational changes in HisP: molecular dynamics simulations of an ABC transport-
er nucleotide-binding domain, Biophys. J. 87 (2004) 3703–3715.
[28] J.H. Miller, Experiments in Molecular Genetics, Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, 1972.
[29] K.D. Tartoff, C.A. Hobbs, Improved media for growing plasmid and cosmid clones,
Bethesda Res. Labs Focus 9 (1987) 12.
[30] V. Eckey, D. Weidlich, H. Landmesser, U. Bergmann, E. Schneider, The second extra-
cellular loop of pore-forming subunits of ATP-binding cassette transporters for basic
amino acids plays a crucial role in interaction with the cognate solute binding pro-
tein(s), J. Bacteriol. 192 (2010) 2150–2159.
[31] A. Vahedi-Faridi, V. Eckey, F. Scheffel, C. Alings, H. Landmesser, E. Schneider, W.
Saenger, Crystal structures and mutational analysis of the arginine-, lysine-,
histidine-binding protein ArtJ from Geobacillus stearothermophilus. Implications for
116 J. Heuveling et al. / Biochimica et Biophysica Acta 1838 (2014) 106–116interactions of ArtJ with its cognate ATP-binding cassette transporter, Art (MP)2, J.
Mol. Biol. 375 (2008) 448–459.
[32] T.K. Ritchie, Y.V. Grinkova, T.H. Bayburt, I.G. Denisov, J.K. Zolnerciks, W.M. Atkins,
S.G. Sligar, Reconstitution of membrane proteins in phospholipid bilayer nanodiscs,
Methods Enzymol. 464 (2008) 211–232.
[33] P. Wessig, R.Wawrzinek, K.Möllnitz, E. Feldbusch, U. Schilde, A new class of ﬂuores-
cent dyes based on 1,3-benzodioxole and [1,3]-dioxolo[4.5-f]benzodioxole, Tetrahe-
dron Lett. 52 (2011) 6192–6195.
[34] R. Wawrzinek, P. Wessig, K. Möllnitz, J. Nikolaus, R. Schwarzer, P. Müller, A.
Herrmann, DBD dyes as ﬂuorescent probes for sensing lipophilic environments,
Bioorg. Med. Chem. Lett. 22 (2012) 5367–5371.
[35] C.E. Liu, P.Q. Liu, G.F.-L. Ames, Characterization of the adenosine triphosphatase ac-
tivity of the periplasmic histidine permease, a trafﬁc ATPase (ABC transporter), J.
Biol. Chem. 272 (1997) 21883–21891.
[36] C.E. Liu, G.F. Ames, Characterization of transport through the periplasmic histidine per-
measeusingproteoliposomes reconstitutedbydialysis, Biol. Chem. 272 (1997)859–866.
[37] T.H. Bayburt, S.G. Sligar, Membrane protein assembly into nanodiscs, FEBS Lett. 584
(2010) 1721–1727.
[38] I. Hänelt, D. Wunnicke, E. Bordignon, H.J. Steinhoff, D.J. Slotboom, Conformational het-
erogeneity of the aspartate transporter Glt(Ph), Nat. Struct. Mol. Biol. 20 (2013)
210–214.
[39] D. Weidlich, N. Wiesemann, J. Heuveling, K. Wardelmann, H. Landmesser, K.
Behnam Sani, C. Worth, R. Preissner, E. Schneider, Residues of a proposed gate
region in type I ATP-binding cassette import systems are crucial for function
as revealed by mutational analysis, Biochim. Biophys. Acta 1828 (2013)
2164–2172.
[40] C. Orelle, T. Ayvaz, R.M. Everly, C.S. Klug, A.L. Davidson, Both maltose-binding pro-
tein and ATP are required for nucleotide-binding domain closure in the intact malt-
ose ABC transporter, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 12837–12842.
[41] M.L. Oldham, J. Chen, Crystal structure of themaltose transporter in a pretranslocation
intermediate state, Science 332 (2011) 1202–1205.[42] G. Lu, J.M. Westbrooks, A.L. Davidson, J. Chen, ATP hydrolysis is required to reset the
ATP-binding cassette dimer into the resting-state conformation, Proc. Natl. Acad. Sci.
(USA) 102 (2005) 17969–17974.
[43] M.L. Daus, H. Landmesser, A. Schlosser, P. Müller, A. Herrmann, E. Schneider, ATP in-
duces conformational changes of periplasmic loop regions of the maltose
ATP-binding cassette transporter, J. Biol. Chem. 281 (2006) 3856–3865.
[44] M. Grote, Y. Polyhach, G. Jeschke, H.J. Steinhoff, E. Schneider, E. Bordignon, Trans-
membrane signaling in the maltose ABC transporter MalFGK2-E. Periplasmic
MalF-P2 loop communicates substrate availability to the ATP-bound MalK dimer,
J. Biol. Chem. 284 (2009) 17521–17526.
[45] M.L. Daus, M. Grote, P. Müller, M. Doebber, A. Herrmann, H.J. Steinhoff, E.
Dassa, E. Schneider, ATP-driven MalK dimer closure and reopening and confor-
mational changes of the “EAA” motifs are crucial for function of the maltose
ATP-binding cassette transporter (MalFGK2), J. Biol. Chem. 282 (2007)
22387–22396.
[46] D.M. Speiser, G.F. Ames, Salmonella typhimurium histidine periplasmic permease
mutations that allow transport in the absence of histidine-binding proteins, J.
Bacteriol. 173 (1991) 1444–1451.
[47] P.Q. Liu, C.E. Liu, G.F. Ames, Modulation of ATPase activity by physical disengage-
ment of the ATP-binding domains of an ABC transporter, the histidine permease, J.
Biol. Chem. 274 (1999) 18310–18318.
[48] C.E. Liu, P.Q. Liu, A. Wolf, E. Lin, G.F.-L. Ames, Both lobes of the soluble receptor
of the periplasmic histidine permease, an ABC transporter (trafﬁc ATPase), in-
teract with the membrane-bound complex, J. Biol. Chem. 274 (1999)
739–747.
[49] E. Bordignon, M. Grote, E. Schneider, The maltose ATP-binding cassette transporter
in the 21st century — towards a structural dynamic perspective on its mode of ac-
tion, Mol. Microbiol. 77 (2010) 1354–1366.
[50] N.S. Kadaba, J.T. Kaiser, E. Johnson, A. Lee, D.C. Rees, The high-afﬁnity E. coli methi-
onine ABC transporter: structure and allosteric regulation, Science 321 (2008)
250–253.
